BG108034A - Фармацевтичен състав, съдържащ циталопрам - Google Patents

Фармацевтичен състав, съдържащ циталопрам Download PDF

Info

Publication number
BG108034A
BG108034A BG108034A BG10803403A BG108034A BG 108034 A BG108034 A BG 108034A BG 108034 A BG108034 A BG 108034A BG 10803403 A BG10803403 A BG 10803403A BG 108034 A BG108034 A BG 108034A
Authority
BG
Bulgaria
Prior art keywords
citalopram
active ingredient
pharmaceutically acceptable
particle size
granulate
Prior art date
Application number
BG108034A
Other languages
Bulgarian (bg)
English (en)
Inventor
Ken Liljegren
Per Holm
Original Assignee
H.Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H.Lundbeck A/S filed Critical H.Lundbeck A/S
Publication of BG108034A publication Critical patent/BG108034A/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG108034A 2001-01-05 2003-07-28 Фармацевтичен състав, съдържащ циталопрам BG108034A (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200100016 2001-01-05

Publications (1)

Publication Number Publication Date
BG108034A true BG108034A (bg) 2005-02-28

Family

ID=8159961

Family Applications (1)

Application Number Title Priority Date Filing Date
BG108034A BG108034A (bg) 2001-01-05 2003-07-28 Фармацевтичен състав, съдържащ циталопрам

Country Status (22)

Country Link
US (1) US20040058989A1 (ru)
EP (1) EP1351667A1 (ru)
JP (1) JP2004517111A (ru)
KR (1) KR20030070088A (ru)
CN (1) CN1484523A (ru)
AU (1) AU2001100195B4 (ru)
BG (1) BG108034A (ru)
BR (1) BR0206272A (ru)
CA (1) CA2358356A1 (ru)
CZ (1) CZ20032119A3 (ru)
EA (1) EA005596B1 (ru)
HR (1) HRP20030546A2 (ru)
HU (1) HUP0302531A3 (ru)
IL (1) IL156547A0 (ru)
IS (1) IS6857A (ru)
MX (1) MXPA03005965A (ru)
NO (1) NO20033073D0 (ru)
PL (1) PL362358A1 (ru)
SK (1) SK9912003A3 (ru)
WO (1) WO2002053133A1 (ru)
YU (1) YU54503A (ru)
ZA (1) ZA200304860B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2406592C (en) * 2002-10-04 2003-09-30 Duchesnay Inc. Method of preparing pharmaceutical dosage forms containing multiple active ingredients
JP2006520390A (ja) * 2003-03-14 2006-09-07 ムルイェ、ニルマル 徐放性錠剤の製造方法
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
WO2006123243A2 (en) * 2005-05-20 2006-11-23 Aurobindo Pharma Limited Pharmaceutical dosage forms comprising escitalopram in form of granules
CN100353939C (zh) * 2006-01-05 2007-12-12 昆明积大制药有限公司 含西酞普兰和环糊精的抗抑郁口服药用组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1358915A (en) * 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
IS6021A (is) * 2000-08-10 2001-10-20 H. Lundbeck A/S Lyfjasamsetningar sem innihalda sítalópram

Also Published As

Publication number Publication date
SK9912003A3 (en) 2003-12-02
PL362358A1 (en) 2004-10-18
KR20030070088A (ko) 2003-08-27
EA200300768A1 (ru) 2003-10-30
AU2001100195A4 (en) 2001-08-16
BR0206272A (pt) 2003-12-30
EA005596B1 (ru) 2005-04-28
JP2004517111A (ja) 2004-06-10
US20040058989A1 (en) 2004-03-25
ZA200304860B (en) 2004-06-30
CA2358356A1 (en) 2002-01-20
AU2001100195B4 (en) 2001-12-20
HUP0302531A3 (en) 2007-06-28
NO20033073L (no) 2003-07-04
NO20033073D0 (no) 2003-07-04
EP1351667A1 (en) 2003-10-15
HRP20030546A2 (en) 2005-06-30
HUP0302531A2 (hu) 2003-11-28
YU54503A (sh) 2006-05-25
IS6857A (is) 2003-06-23
WO2002053133A1 (en) 2002-07-11
MXPA03005965A (es) 2003-09-05
CN1484523A (zh) 2004-03-24
IL156547A0 (en) 2004-01-04
CZ20032119A3 (en) 2004-03-17

Similar Documents

Publication Publication Date Title
EP0747050B2 (en) Pharmaceutical compositions containing irbesartan
US6117451A (en) Direct compression metformin hydrochloride tablets
CA2319201C (en) Celecoxib compositions
AU737738B2 (en) Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
JP2003231634A (ja) バルサルタンの固体経口剤形
US10071059B2 (en) Co-processed tablet excipient composition its preparation and use
WO2008057266A2 (en) Dry granulation binders, products, and use thereof
LV12731B (en) FORMULA FOR ORAL MEDICINAL PRODUCTS
AU748359B2 (en) Controlled-release formulations
EP2496261B1 (en) Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
EP1994926B9 (en) Valsartan formulations
EA036288B1 (ru) Фармацевтические лекарственные формы
JP2003531153A (ja) シタロプラムを含有する薬学的調合物
BG108034A (bg) Фармацевтичен състав, съдържащ циталопрам
FI103179B (fi) Menetelmä muotoiltujen, puristettujen, hidastetusti vapauttavien annos teluyksiköiden valmistamiseksi
RU2463039C2 (ru) Эсциталопрам и твердая фармацевтическая композиция, его содержащая
JPH08310969A (ja) 固形薬品組成物及びその製造方法
EP3875077B1 (en) Dosage form providing prolonged release of tapentadol phosphoric acid salt
EP3511001B1 (en) Pirfenidone-containing tablet and capsule formulation
JP2000516601A (ja) 水溶性化合物及びセルロースを含有する粒状物
JP2022540170A (ja) 医薬調製物
EP0975337B1 (en) Fast release compressed tablet of flurbiprofen
AU2002216944A1 (en) Pharmaceutical composition containing citalopram
RU2822063C2 (ru) Фармацевтический препарат
KR20090052944A (ko) 이르베사르탄을 함유하는 제약 조성물